A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986447 in Healthy Participants
Clinical trial NCT05760937 · COMPLETED
Trial details
- NCT number
- NCT05760937
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2023-11-27
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.